Korean Drug Co. Ltd - Asset Resilience Ratio

Latest as of March 2026: 26.08%

Korean Drug Co. Ltd (014570) has an Asset Resilience Ratio of 26.08% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩25.14 Billion
≈ $17.04 Million USD Cash + Short-term Investments

Total Assets

₩96.39 Billion
≈ $65.32 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Korean Drug Co. Ltd's Asset Resilience Ratio has changed over time. Check 014570 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Korean Drug Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 014570 market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩25.14 Billion 26.08%
Total Liquid Assets ₩25.14 Billion 26.08%

Asset Resilience Insights

  • Very High Liquidity: Korean Drug Co. Ltd maintains exceptional liquid asset reserves at 26.08% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Korean Drug Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Korean Drug Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Biogen Inc
NASDAQ:BIIB
Drug Manufacturers - General 2.74%
Pfizer Inc
SA:PFIZ34
Drug Manufacturers - General 5.48%
AstraZeneca PLC
NYSE:AZN
Drug Manufacturers - General 0.10%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436
Drug Manufacturers - General 17.40%
Aurora Optoelectronics Co Ltd
SHG:600666
Drug Manufacturers - General 5.89%
NanJing Pharmaceutical Co Ltd
SHG:600713
Drug Manufacturers - General 0.85%
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3
Drug Manufacturers - General 7.83%
Firebrick Pharma Ltd
AU:FRE
Drug Manufacturers - General 0.29%

Annual Asset Resilience Ratio for Korean Drug Co. Ltd (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Korean Drug Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 26.62% ₩25.11 Billion
≈ $17.02 Million
₩94.32 Billion
≈ $63.92 Million
+5.29pp
2024-12-31 21.33% ₩18.96 Billion
≈ $12.85 Million
₩88.89 Billion
≈ $60.24 Million
+2.78pp
2023-12-31 18.55% ₩16.64 Billion
≈ $11.28 Million
₩89.71 Billion
≈ $60.79 Million
-9.21pp
2022-12-31 27.76% ₩26.23 Billion
≈ $17.78 Million
₩94.52 Billion
≈ $64.05 Million
-3.52pp
2021-12-31 31.28% ₩27.72 Billion
≈ $18.78 Million
₩88.61 Billion
≈ $60.05 Million
+4.80pp
2020-12-31 26.48% ₩22.07 Billion
≈ $14.95 Million
₩83.34 Billion
≈ $56.48 Million
+11.50pp
2019-12-31 14.98% ₩11.36 Billion
≈ $7.70 Million
₩75.85 Billion
≈ $51.40 Million
+3.16pp
2018-12-31 11.82% ₩8.62 Billion
≈ $5.84 Million
₩72.96 Billion
≈ $49.45 Million
+7.10pp
2017-12-31 4.71% ₩3.15 Billion
≈ $2.13 Million
₩66.79 Billion
≈ $45.27 Million
-1.58pp
2016-12-31 6.30% ₩3.99 Billion
≈ $2.71 Million
₩63.41 Billion
≈ $42.97 Million
+5.71pp
2015-12-31 0.59% ₩350.05 Million
≈ $237.22K
₩59.20 Billion
≈ $40.12 Million
+0.58pp
2014-12-31 0.01% ₩4.68 Million
≈ $3.17K
₩62.17 Billion
≈ $42.13 Million
--
pp = percentage points

About Korean Drug Co. Ltd

KQ:014570 Korea Drug Manufacturers - General
Market Cap
$24.65 Million
₩36.38 Billion KRW
Market Cap Rank
#24376 Global
#1713 in Korea
Share Price
₩3360.00
Change (1 day)
+0.00%
52-Week Range
₩3120.00 - ₩4710.00
All Time High
₩13030.58
About

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products.… Read more